Cargando…
Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience
Background COVID-19 pandemic disrupted heath care system all around the world and overwhelmed the capacity of hospital to manage regular patients including cancer patients. We implemented a new program to help managing oncology patients visited our Emergency Rooms (ER) and discharged home. Methods O...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330348/ http://dx.doi.org/10.1182/blood-2020-141782 |
_version_ | 1783732697169920000 |
---|---|
author | Gmati, Giamal Edin Mabsut, Nadine Matar, Zainab Alshami, Mona Shahata, Husam Alkhesaifi, Areej Alharbi, Mohamed Almutairi, Nashmia Alolayan, Ashwaq Alzahrani, Mohsen Algarni, Abdullah Alhadab, Abdulrahman Hejazi, Ayman Alahmari, Bader Jazieh, Abdul-Rahman |
author_facet | Gmati, Giamal Edin Mabsut, Nadine Matar, Zainab Alshami, Mona Shahata, Husam Alkhesaifi, Areej Alharbi, Mohamed Almutairi, Nashmia Alolayan, Ashwaq Alzahrani, Mohsen Algarni, Abdullah Alhadab, Abdulrahman Hejazi, Ayman Alahmari, Bader Jazieh, Abdul-Rahman |
author_sort | Gmati, Giamal Edin |
collection | PubMed |
description | Background COVID-19 pandemic disrupted heath care system all around the world and overwhelmed the capacity of hospital to manage regular patients including cancer patients. We implemented a new program to help managing oncology patients visited our Emergency Rooms (ER) and discharged home. Methods Our home care program designed to cover all aspects of patients care while they are at home by checking the ER list on daily basis and identify all oncology patients on this list. We developed an algorithm, to follow up our patients and the COVID-19 test status and to act accordingly (figure 1). The team consists of oncologist, oncology nurse specialists, patient educator and data management person. The primary oncologist of each patient is notified and consulted on the plan. The team follows the result and decide further steps of management accordingly. The intervention includes regular clinical assessment by calling the patient, arranging medication delivery, sending patients brochures explaining the necessary protective measured needs to be taken by patient and care givers and respond to patient and family queries and concerns. Results Between May 31 and July 31, 237 oncology patients seen in ED with different clinical presentations. One hundred forty two patients did not need admission and therefore discharged home. COVID-19 test was carried out according to the presenting symptoms and ARI score (test requested if score is 4 or more). Only 30 patients (21%) needed COVID-19 testing prior to discharge from ED and 6 patients tested positive. However, on our follow of those patients at home further 16 patients (11%) needed to be tested due to new developments of their symptoms and 3 patients tested positive. The main reasons for nor requesting COVID-19 for some patients either 1) recent testing in outpatient clinics or other health centers outside our institution Ministry of Health, 2) they are known to have covid-19 and still in active infection, 3) based on patient's MRP decision not to swab patient for COVID -19. During our daily monitoring of patients at their homes, 12 patients (8%) were called back due to worsening of their symptoms and needed further assessment and management after discussion with their MRP. As per our infection control department guidelines, repeating COVID-19 testing for asymptomatic patients was not necessary and patient can be discharged from our records. This new model of care in our institution was presented to the COVID-19 pandemic command center and the program got the approval and recommended to be implemented in other departments as per patients need. Conclusion Oncology patients are vulnerable especially at this time of COVID-19 pandemic and our program is designed to reduce the risk of exposure and infection by looking after those patient while they are at home in addition to maintain the continuity of their cancer management. [Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare. |
format | Online Article Text |
id | pubmed-8330348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-83303482021-08-03 Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience Gmati, Giamal Edin Mabsut, Nadine Matar, Zainab Alshami, Mona Shahata, Husam Alkhesaifi, Areej Alharbi, Mohamed Almutairi, Nashmia Alolayan, Ashwaq Alzahrani, Mohsen Algarni, Abdullah Alhadab, Abdulrahman Hejazi, Ayman Alahmari, Bader Jazieh, Abdul-Rahman Blood 903.Health Services Research-Malignant Conditions (Myeloid Disease) Background COVID-19 pandemic disrupted heath care system all around the world and overwhelmed the capacity of hospital to manage regular patients including cancer patients. We implemented a new program to help managing oncology patients visited our Emergency Rooms (ER) and discharged home. Methods Our home care program designed to cover all aspects of patients care while they are at home by checking the ER list on daily basis and identify all oncology patients on this list. We developed an algorithm, to follow up our patients and the COVID-19 test status and to act accordingly (figure 1). The team consists of oncologist, oncology nurse specialists, patient educator and data management person. The primary oncologist of each patient is notified and consulted on the plan. The team follows the result and decide further steps of management accordingly. The intervention includes regular clinical assessment by calling the patient, arranging medication delivery, sending patients brochures explaining the necessary protective measured needs to be taken by patient and care givers and respond to patient and family queries and concerns. Results Between May 31 and July 31, 237 oncology patients seen in ED with different clinical presentations. One hundred forty two patients did not need admission and therefore discharged home. COVID-19 test was carried out according to the presenting symptoms and ARI score (test requested if score is 4 or more). Only 30 patients (21%) needed COVID-19 testing prior to discharge from ED and 6 patients tested positive. However, on our follow of those patients at home further 16 patients (11%) needed to be tested due to new developments of their symptoms and 3 patients tested positive. The main reasons for nor requesting COVID-19 for some patients either 1) recent testing in outpatient clinics or other health centers outside our institution Ministry of Health, 2) they are known to have covid-19 and still in active infection, 3) based on patient's MRP decision not to swab patient for COVID -19. During our daily monitoring of patients at their homes, 12 patients (8%) were called back due to worsening of their symptoms and needed further assessment and management after discussion with their MRP. As per our infection control department guidelines, repeating COVID-19 testing for asymptomatic patients was not necessary and patient can be discharged from our records. This new model of care in our institution was presented to the COVID-19 pandemic command center and the program got the approval and recommended to be implemented in other departments as per patients need. Conclusion Oncology patients are vulnerable especially at this time of COVID-19 pandemic and our program is designed to reduce the risk of exposure and infection by looking after those patient while they are at home in addition to maintain the continuity of their cancer management. [Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare. American Society of Hematology 2020-11-05 2021-08-03 /pmc/articles/PMC8330348/ http://dx.doi.org/10.1182/blood-2020-141782 Text en Copyright © 2020 American Society of Hematology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | 903.Health Services Research-Malignant Conditions (Myeloid Disease) Gmati, Giamal Edin Mabsut, Nadine Matar, Zainab Alshami, Mona Shahata, Husam Alkhesaifi, Areej Alharbi, Mohamed Almutairi, Nashmia Alolayan, Ashwaq Alzahrani, Mohsen Algarni, Abdullah Alhadab, Abdulrahman Hejazi, Ayman Alahmari, Bader Jazieh, Abdul-Rahman Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience |
title | Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience |
title_full | Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience |
title_fullStr | Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience |
title_full_unstemmed | Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience |
title_short | Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience |
title_sort | home care program for managing oncology patients during covid-19 pandemic. a tertiary referral center experience |
topic | 903.Health Services Research-Malignant Conditions (Myeloid Disease) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330348/ http://dx.doi.org/10.1182/blood-2020-141782 |
work_keys_str_mv | AT gmatigiamaledin homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT mabsutnadine homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT matarzainab homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT alshamimona homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT shahatahusam homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT alkhesaifiareej homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT alharbimohamed homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT almutairinashmia homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT alolayanashwaq homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT alzahranimohsen homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT algarniabdullah homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT alhadababdulrahman homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT hejaziayman homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT alahmaribader homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience AT jaziehabdulrahman homecareprogramformanagingoncologypatientsduringcovid19pandemicatertiaryreferralcenterexperience |